Dec 06, 2013 at 17:00 | Source: CNBC-TV18
Announcement of tapering could bring about a sea change in foreign exchange in January, which would lead the dollar to strengthen against other currencies like yen, euro, which in turn would be good for Japanese and European equities but bad news for emerging markets, says Nakisa
Dec 06, 2013 at 15:18 | Source: Reuters
The rupee has gained 1.2 percent against the dollar so far this week as exit polls predicted a strong showing for the key opposition party.
Dec 06, 2013 at 15:04 | Source: Reuters
Aiding Brent's rise was data on Thursday that showed the US economy grew faster than initially estimated in the third quarter, suggesting oil demand could improve in the world's top consumer.
Dec 06, 2013 at 15:01 | Source: Moneycontrol.com
Global markets are under pressure as strong eco data from us reinforces view that taper may come earlier than expected. Asia ends with 0.5 percent cut on an average.
Dec 06, 2013 at 12:21 | Source: Moneycontrol.com
The rupee trades flat against the US dollar, tracking rise in euro and firm local shares. The currency eyes US jobs data and domestic state elections results, while gilts are trading down ahead of Rs 15,000 crore-rupee gilt auction and US non-farms payroll data today.
Dec 06, 2013 at 10:09 | Source: Reuters
The US economy grew faster than initially estimated in the third quarter, data also showed on Thursday, suggesting demand could improve in the world's top oil consumer.
Dec 06, 2013 at 09:41 | Source: CNBC-TV18
Chris Wood of CLSA says Greed & Fear believes that the US economy does not have a strong cyclical momentum. The lacklustre trend in capex in the US is in large part the consequence of the zero rate policy, not in spite of it, he adds.
Dec 05, 2013 at 15:28 | Source: PTI
In a statement, the company said one of its manufacturing facilities, Jubilant HollisterStier, LLC (JHS) located at Spokane, Washington state, US has been issued a warning letter by US Food and Drug Administration (USFDA).
Dec 05, 2013 at 12:29 | Source: Moneycontrol.com
Jubilant expects that the on-going manufacturing, distribution and sale of products from this facility will not be impacted as the WL will affect new approvals only.
Dec 05, 2013 at 11:15 | Source: Moneycontrol.com
Jubilant Life Sciences' manufacturing facilities, Jubilant HollisterStier, LLC (JHS) located at Spokane, Washington State, US has been issued a Warning Letter (WL) by US Food and Drug Administration (FDA).